Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1990
Intraperitoneal recombinant alpha-2-interferon alternating with cisplatin as salvage therapy for minimal residual-disease ovarian cancer: a phase II study
M Nardi, F Cognetti, C F Pollera, et al.
Cancer Research
|
June 1, 1991
Expression of CAR-3 and TAG-72 macromolecules in normal and transformed endometrium: potential diagnostic application in postmenopausal patients
A Bartolazzi, M Mottolese, A Vocaturo, et al.
Cancer
|
October 15, 1991
The use of a panel of monoclonal antibodies can lower false-negative diagnoses of peritoneal washings in ovarian tumors
M Mottolese, M Salzano, C Vincenzoni, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
A combination of ifosfamide and mitoxantrone as salvage therapy in patients with advanced ovarian cancer
M Nardi, M Della Giulia, C F Pollera, et al.
International Journal of Cancer
|
July 30, 1992
Immunocytodiagnosis of atypical hyperplasia and endometrial carcinoma in post-menopausal women
M Mottolese, A Vocaturo, A Bartolazzi, et al.
Gynecologic Oncology
|
April 1, 1994
Noninvasive monitoring of ovarian cancer: improved results using CT with intraperitoneal contrast combined with immunocytology
S Giunta, I Venturo, M Mottolese, et al.
Gynecologic Oncology
|
November 25, 1998
Vulvar squamous carcinoma: prognostic role of DNA content
L Mariani, L Conti, G Atlante, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1990
Intraperitoneal recombinant alpha-2-interferon alternating with cisplatin as salvage therapy for minimal residual-disease ovarian cancer: a phase II study
M Nardi, F Cognetti, C F Pollera, et al.
Cancer Research
|
June 1, 1991
Expression of CAR-3 and TAG-72 macromolecules in normal and transformed endometrium: potential diagnostic application in postmenopausal patients
A Bartolazzi, M Mottolese, A Vocaturo, et al.
Cancer
|
October 15, 1991
The use of a panel of monoclonal antibodies can lower false-negative diagnoses of peritoneal washings in ovarian tumors
M Mottolese, M Salzano, C Vincenzoni, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
A combination of ifosfamide and mitoxantrone as salvage therapy in patients with advanced ovarian cancer
M Nardi, M Della Giulia, C F Pollera, et al.
International Journal of Cancer
|
July 30, 1992
Immunocytodiagnosis of atypical hyperplasia and endometrial carcinoma in post-menopausal women
M Mottolese, A Vocaturo, A Bartolazzi, et al.
Gynecologic Oncology
|
April 1, 1994
Noninvasive monitoring of ovarian cancer: improved results using CT with intraperitoneal contrast combined with immunocytology
S Giunta, I Venturo, M Mottolese, et al.
Gynecologic Oncology
|
November 25, 1998
Vulvar squamous carcinoma: prognostic role of DNA content
L Mariani, L Conti, G Atlante, et al.
Page
of 2